Future of Drug Delivery: Novel Approaches to Targeted Therapies

New England Structural Biology Association (NESBA) presents a one day conference on Future of Drug Delivery: Novel Approaches to Targeted Therapies.

The ability to deliver the right drug, at the right time, in the right location, would revolutionize the treatment of many diseases. Such targeted therapies and precision medicines will necessarily be required for the treatment of the biggest health challenges of the 21st century. This NESBA meeting, entitled "Future of drug delivery: novel approaches to targeted therapies", focuses on cutting edge delivery systems based on polymers, lipids, conjugates, and advanced nanoengineered systems containing all types of cargos (proteins, RNA, cells, small molecules, vaccines, imaging and diagnostic agents). Our volunteer organizers have assembled an outstanding lineup of accomplished scientists from academia and industry to provide the best examples in our community.

LaCava Center
Bentley University
Waltham, MA
Thursday, May 7, 2015
8:00 am - 6:00 pm


8:00-8:50 AM Registration and light breakfast
8:50-9:00 AM Opening remarks: Raj Chopra (NESBA)
Session 1: Drug Delivery Systems/Tissue Targeting Chair: Ed Randles (Vertex)
9:00-10:00 AM Keynote: Mansoor Amiji (Northeastern) 
Translational Nanomedicine: Targeted Therapeutic Delivery for Cancer, Pain, and Inflammatory Diseases
10:00-10:45 AM Dan Kohane (HMS/Children's Hospital) 
Targeted and Triggered Delivery
10:45-11:00 PM Tea Break
Session 2: Targeted Drug Delivery: Oncology Chair: Nan Ji (Novartis)
11:00 - 11:45 AM Daryl Drummond (Merrimack Pharmaceuticals, Inc) 
Development and Clinical Translation of Antibody-Targeted Nanotherapeutics
11:45 - 12:15 PMMatt Pavao & Lian Ouyang (Cooley LLP) 
Patents and Drug Delivery
12:15 - 1:15 PM Lunch
1:15 - 2:00 PM Dane Wittrup (MIT) 
Tumor Targeting: Wishful Thinking v. Reality in Immunocytokine Design
Session 3: Intracellular Delivery of Macromolecules, Nucleic acids Chair: Kumkum Saxena (Vertex)
2:00 - 3:00 PM Keynote: Vincent Rotello (UMass Amherst) 
Interfacing Nanomaterials with Biology: Applications in Therapeutics and Diagnostics
3:00 - 3:15PM Tea Break
3:15 - 4:00 PM Thai Thayumanavan (UMass Amherst) 
Bottom-up Approaches to a Versatile Nanogel Delivery Platform
4:00 - 4:45 PM Omar Khan (Dan Anderson lab, MIT) 
Enabling RNA as a therapeutic through nanotechnology platforms
Session 4: Industrial Panel Discussion Chair: Richard Korsmeyer (Pfizer)
4:45 - 5:15 PM  Steve Faraci (Cyta Therapeutics)
Terry Robinson (Catalent Applied Drug Delivery Institute)
Phil Snyder (Vertex)
5:15 - 6:30 PM Reception


Meeting Organizers

Back to top